Semaglutide is a medicine that helps in lowering blood sugar levels
This iron overload can be due to disrupted iron homeostasis, increased iron absorption via transferrin receptors, or decreased iron export via ferroportin
Regular monitoring of blood glucose levels is essential to avoid this condition
Some patients gained weight, others lost weight, but its unclear if sitagliptin caused these changes
Headaches and dizziness Headaches are reported by a significant minority of patients, particularly early in treatment
GLP-1 medications, such as semaglutide (Wegovy, Ozempic) and tirzepatide (Mounjaro, Zepbound), were originally developed for type 2 diabetes and later approved for chronic weight management at full therapeutic doses